Table of Contents
Introduction
In recent years, medications that help with weight loss have gained a lot of attention. More people are looking for effective ways to manage their weight, especially as obesity rates continue to rise. With new treatments available, many are turning to prescription medications that were originally developed for diabetes but have been found to support weight loss as well. Two of the most talked-about medications in this category are tirzepatide and semaglutide. Both have been approved by the U.S. Food and Drug Administration (FDA) for treating type 2 diabetes, and both have also been studied for their ability to help people lose weight. But which one is better? How do they work? What are the risks? These are some of the biggest questions people are asking.
Tirzepatide and semaglutide belong to a class of medications called GLP-1 receptor agonists. These drugs work by mimicking a hormone in the body that helps control blood sugar, slow digestion, and reduce appetite. When people eat, their bodies naturally release this hormone to help regulate how food is processed. However, in people with obesity or type 2 diabetes, this process may not work as well as it should. Medications like tirzepatide and semaglutide help by increasing the effects of this hormone, making people feel fuller for longer and helping them eat less. The result? Many people experience significant weight loss while taking these drugs.
While both medications are similar in some ways, they also have key differences. Semaglutide is a GLP-1 receptor agonist, meaning it only targets one type of hormone. Tirzepatide, on the other hand, is a dual agonist, meaning it acts on two different hormones—GLP-1 and another hormone called GIP (glucose-dependent insulinotropic polypeptide). Because tirzepatide works on both pathways, some studies suggest it may lead to greater weight loss compared to semaglutide. However, other factors, such as side effects, availability, and cost, also play a role in determining which medication is the right choice for an individual.
With the growing popularity of these medications, many people are searching for reliable information online. They want to know how much weight they can expect to lose, how long they will need to take the medication, and whether it is safe for them. They also have questions about insurance coverage and whether they can take these drugs if they do not have diabetes. The goal of this article is to answer the most common questions people ask about tirzepatide and semaglutide.
This article will explain how these medications work, compare their effectiveness, discuss their safety, and provide details about costs and availability. By the end, readers will have a clear understanding of the differences between tirzepatide and semaglutide and what they should consider before choosing one.
As with any medication, it is important to talk to a doctor before starting tirzepatide or semaglutide. While these drugs can be very effective for weight loss, they are not suitable for everyone. People with certain medical conditions, such as a history of pancreatitis or thyroid cancer, may not be good candidates. Additionally, both medications can have side effects, and not everyone will respond to them in the same way.
The field of weight loss medications is constantly evolving. Researchers continue to study how these drugs work and whether they can be improved. New medications may also become available in the future. However, for now, tirzepatide and semaglutide are two of the most powerful options available for people struggling with weight loss.
By answering the top 10 questions people ask about these medications, this article will provide a detailed comparison of tirzepatide and semaglutide. Whether someone is considering starting one of these treatments or just wants to understand more about how they work, this guide will offer clear, evidence-based information to help them make an informed decision.
What Are Tirzepatide and Semaglutide?
Tirzepatide and semaglutide are medications that have gained popularity for their ability to help with weight loss. Originally developed to treat type 2 diabetes, researchers later discovered their powerful effects on appetite control and body weight reduction. Because of this, they are now prescribed not only to people with diabetes but also to those who are overweight or have obesity.
Both of these medications belong to a class of drugs known as GLP-1 receptor agonists. This means they work by mimicking a natural hormone in the body called glucagon-like peptide-1 (GLP-1). This hormone helps regulate blood sugar, digestion, and hunger. However, while both drugs work in similar ways, tirzepatide has an additional mechanism that makes it different from semaglutide.
How Semaglutide Works
Semaglutide is a GLP-1 receptor agonist, meaning it acts like the GLP-1 hormone that the body naturally produces. GLP-1 plays a major role in controlling hunger, digestion, and insulin levels. When semaglutide is taken, it does three important things:
- Slows down digestion – When food stays in the stomach longer, a person feels full for a longer time, leading to reduced calorie intake.
- Decreases hunger – It affects brain receptors that control appetite, making a person feel less hungry overall.
- Helps control blood sugar – It encourages the pancreas to release more insulin after meals, which helps keep blood sugar levels stable.
Because semaglutide makes people feel full and reduces hunger, it helps them eat less and lose weight. It is available under the brand names Ozempic (for diabetes) and Wegovy (for weight loss).
How Tirzepatide Works
Tirzepatide works similarly to semaglutide but has an added feature. It is a dual agonist, which means it activates two different hormone pathways instead of just one. In addition to working on GLP-1 receptors, it also affects another hormone called GIP (glucose-dependent insulinotropic polypeptide).
GIP is another natural hormone that plays a role in regulating metabolism, digestion, and fat storage. Scientists believe that activating both GLP-1 and GIP at the same time leads to greater effects on weight loss and blood sugar control.
Tirzepatide’s dual action has three key benefits:
- Enhances insulin release even more than semaglutide – This means it helps lower blood sugar more effectively.
- Increases fat metabolism – It influences how the body stores and burns fat, which may contribute to better weight loss results.
- Reduces appetite more strongly – Because it activates two hormone pathways instead of one, it may have a greater effect on reducing hunger.
Due to these combined effects, tirzepatide has been shown to produce greater weight loss than semaglutide in clinical studies. It is currently sold under the brand name Mounjaro for diabetes, and approval for weight loss is expected soon.
FDA Approval and Uses
Both medications were first approved by the U.S. Food and Drug Administration (FDA) for treating type 2 diabetes. However, because they also caused significant weight loss, they have been studied and approved (or are in the process of being approved) for weight management as well.
- Semaglutide (Wegovy) was officially approved for weight loss in 2021.
- Tirzepatide (Mounjaro) is currently only FDA-approved for diabetes, but studies show it may be even more effective for weight loss than semaglutide. It is expected to receive official FDA approval for weight loss soon.
Even though tirzepatide is not yet officially approved for weight loss, some doctors are already prescribing it for that purpose because of its strong effects. However, insurance coverage may be an issue, as insurance companies are more likely to cover medications that have official FDA approval for weight loss.
How Do Tirzepatide and Semaglutide Compare?
While both medications help with weight loss and blood sugar control, there are key differences between them.
- Mechanism of Action
Semaglutide works only on GLP-1 receptors, while tirzepatide works on both GLP-1 and GIP receptors. This dual action is believed to give tirzepatide an advantage in weight loss and metabolism. - Weight Loss Effectiveness
Clinical studies suggest that tirzepatide leads to greater weight loss than semaglutide. On average, people taking semaglutide (Wegovy) lost about 15% of their body weight, while those taking tirzepatide lost around 20% of their body weight. - Appetite Suppression
Both medications reduce hunger, but tirzepatide may have a stronger appetite-suppressing effect due to its impact on two hormone pathways instead of just one. - Blood Sugar Control
Both drugs improve blood sugar levels, but tirzepatide appears to have a slightly greater effect on reducing insulin resistance and lowering blood sugar levels compared to semaglutide. - FDA Approval for Weight Loss
Semaglutide is already approved for weight loss under the brand name Wegovy, while tirzepatide is expected to be approved soon but is currently only approved for diabetes treatment. - Insurance Coverage
Because semaglutide is officially FDA-approved for weight loss, it may be easier to get insurance coverage for Wegovy. Tirzepatide (Mounjaro) may not be covered unless prescribed for diabetes, though this could change once it receives weight loss approval.
Why These Medications Matter
Obesity is a serious health problem worldwide, and losing weight is not easy for many people. Traditional methods like diet and exercise often do not lead to long-term success. Medications like tirzepatide and semaglutide offer new hope by helping people control their appetite, reduce calorie intake, and lose significant amounts of weight.
For people with conditions such as type 2 diabetes, high blood pressure, or heart disease, these medications can improve both weight and overall health. Losing weight can reduce the risk of serious health problems, including heart attacks, strokes, and complications from diabetes.
Understanding how these medications work helps people make informed decisions when talking to their doctors. Whether tirzepatide or semaglutide is better depends on a person’s individual health needs, insurance coverage, and how well they tolerate each medication. Both options have helped thousands of people achieve weight loss success, and ongoing research may lead to even better treatments in the future.
Which Is More Effective for Weight Loss: Tirzepatide or Semaglutide?
Tirzepatide and semaglutide are two of the most powerful medications for weight loss. Both are originally designed for diabetes treatment but have also been approved or studied for obesity management. Many people wonder which one works better. To answer this, scientists have compared them in clinical trials. The results show that while both drugs lead to significant weight loss, tirzepatide appears to be more effective. However, individual results may vary based on personal health, diet, and lifestyle.
Comparing Weight Loss Results from Clinical Trials
Researchers have tested both medications in large clinical studies. These studies help doctors understand how well each drug works for weight loss.
- Semaglutide – The STEP Trials:
- The STEP clinical trials focused on semaglutide for weight loss.
- In the STEP 1 trial, participants who took 2.4 mg of semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks.
- Those who took a placebo (a fake treatment) only lost about 2.4% of their body weight in the same period.
- This showed that semaglutide significantly helped people lose weight compared to no treatment.
- Tirzepatide – The SURMOUNT Trials:
- The SURMOUNT-1 trial studied tirzepatide for weight loss.
- Participants took different doses of tirzepatide (5 mg, 10 mg, or 15 mg) weekly for 72 weeks.
- On the highest dose (15 mg), people lost an average of 22.5% of their body weight.
- The lower doses (5 mg and 10 mg) also led to significant weight loss, about 15% to 20% of body weight.
- People who received a placebo lost only 2.4% of their weight, similar to the semaglutide study.
Comparing these results, tirzepatide (15 mg) led to greater weight loss than semaglutide (2.4 mg). On average, people on tirzepatide lost about 7% more body weight than those on semaglutide. This suggests that tirzepatide might be more powerful for weight loss.
Why Does Tirzepatide Seem to Work Better?
Tirzepatide works differently from semaglutide. Both drugs activate GLP-1 receptors, which help control blood sugar and reduce hunger. However, tirzepatide also activates another hormone receptor called GIP (glucose-dependent insulinotropic polypeptide). This second action may help the body use energy better and burn more fat.
- Dual Mechanism of Tirzepatide
- GLP-1 reduces hunger and slows stomach emptying.
- GIP helps the body process fats and sugars more effectively.
- Together, these effects may explain why tirzepatide causes greater weight loss.
- Higher Doses of Tirzepatide Compared to Semaglutide
- Tirzepatide’s maximum dose is 15 mg per week, while semaglutide’s is 2.4 mg per week for weight loss.
- This higher dose may also contribute to better results.
Factors That Affect Weight Loss Results
Even though clinical trials show that tirzepatide leads to more weight loss than semaglutide, not everyone will have the same experience. Several factors can influence how much weight a person loses:
- Starting Weight and Body Composition
- People who weigh more at the beginning may lose more pounds but a similar percentage of body weight.
- Some individuals may lose more fat, while others may also lose muscle.
- Diet and Exercise
- These medications help reduce hunger, but eating a healthy diet still matters.
- Regular exercise can improve weight loss results and help maintain muscle.
- Side Effects and Tolerability
- Both drugs can cause nausea, vomiting, and stomach discomfort.
- If someone cannot tolerate the medication, they may need to take a lower dose, which could affect their weight loss results.
- Medical Conditions and Medications
- People with diabetes, thyroid issues, or other health conditions may lose weight at different rates.
- Some medications (such as insulin or steroids) may slow down weight loss.
Which One Should You Choose?
For people looking for the most effective option, tirzepatide may offer greater weight loss than semaglutide. However, effectiveness is not the only factor to consider. Some people may tolerate one medication better than the other. Others may prefer semaglutide if they have insurance coverage for it but not for tirzepatide.
Doctors will often help patients decide based on:
- Their weight loss goals
- Their overall health
- Possible side effects
- Insurance coverage and cost
Tirzepatide appears to be the stronger weight loss drug, but semaglutide is still highly effective. Either medication can help with significant weight loss when used correctly and combined with healthy lifestyle changes.
How Do Tirzepatide and Semaglutide Work in the Body?
Tirzepatide and semaglutide help people lose weight by affecting hormones that control hunger, digestion, and how the body handles sugar. Both medications work by mimicking a natural hormone in the body called GLP-1 (glucagon-like peptide-1). However, tirzepatide also works on another hormone called GIP (glucose-dependent insulinotropic polypeptide), making it a dual agonist. Understanding how these drugs work can explain why they are effective for weight loss.
The Role of GLP-1 and GIP in Appetite and Digestion
The body naturally produces GLP-1 after eating. This hormone signals the brain to feel full, slows down the stomach’s emptying process, and helps regulate blood sugar levels by increasing insulin production. Semaglutide mimics this hormone, making the body react as if it has just eaten a meal, even when food intake is reduced.
Tirzepatide, on the other hand, works on both GLP-1 and GIP receptors. Like GLP-1, GIP plays a role in blood sugar control, but it also affects fat metabolism. Scientists believe that by acting on both receptors, tirzepatide can have a stronger effect on weight loss and blood sugar regulation than semaglutide alone.
Both medications impact multiple systems in the body, leading to reduced hunger, slower digestion, and changes in how fat and sugar are processed.
Reducing Hunger and Controlling Appetite
One of the most powerful effects of tirzepatide and semaglutide is their ability to suppress hunger. The brain controls appetite through a balance of hormones and signals. GLP-1 and GIP work on parts of the brain that regulate food intake, particularly the hypothalamus, which controls feelings of hunger and fullness.
When these medications activate GLP-1 (and for tirzepatide, GIP), they send signals to the brain that reduce cravings and make people feel satisfied with less food. This effect helps people eat fewer calories naturally, leading to gradual weight loss without feeling starved.
Studies show that people taking these medications often report less interest in food, a decreased desire for high-calorie meals, and an overall feeling of being full longer after eating. This makes it easier to stick to a lower-calorie diet, which is necessary for weight loss.
Slowing Down Digestion for Better Portion Control
Another key way tirzepatide and semaglutide help with weight loss is by slowing gastric emptying—the process by which food moves from the stomach to the small intestine.
Normally, after eating, food quickly passes from the stomach to be absorbed by the intestines. When food leaves the stomach too fast, people feel hungry sooner and may eat more than needed. By slowing this process, both medications keep food in the stomach longer, increasing the feeling of fullness after meals.
For example, someone who eats a regular-sized meal while on semaglutide or tirzepatide may feel satisfied for many hours, reducing the urge to snack or overeat later in the day. This extended fullness helps people naturally eat less over time.
Improving Insulin Sensitivity and Blood Sugar Control
While originally developed for type 2 diabetes, both tirzepatide and semaglutide improve insulin sensitivity, which means the body can use insulin more efficiently to manage blood sugar levels.
After eating, the body releases insulin to help process sugars from food. In people with insulin resistance, common in obesity and type 2 diabetes, the body does not respond well to insulin, leading to high blood sugar levels and difficulty losing weight.
By mimicking GLP-1 (and for tirzepatide, GIP), these medications help insulin work more effectively. This leads to:
- Lower blood sugar levels
- Reduced fat storage, especially around the abdomen
- A healthier metabolism
Even in people without diabetes, improving insulin function can help prevent future metabolic diseases and make weight loss more effective.
How Dual Agonist Action Makes Tirzepatide Different
The biggest difference between tirzepatide and semaglutide is tirzepatide’s ability to activate both GLP-1 and GIP receptors.
- GLP-1 reduces appetite, slows digestion, and improves insulin function
- GIP supports insulin release and affects fat metabolism
Research suggests that GIP activation may have additional benefits beyond what GLP-1 alone provides. Some studies show that tirzepatide leads to greater weight loss than semaglutide, possibly because GIP helps the body process fat more efficiently.
By working on two hormonal pathways instead of just one, tirzepatide may provide a stronger and more sustained weight loss effect compared to semaglutide. However, more research is needed to fully understand all the differences.
Why These Effects Lead to Weight Loss
The combined effects of reduced hunger, slower digestion, and improved insulin function create a powerful approach to weight loss. People taking these medications naturally consume fewer calories, experience fewer cravings, and burn fat more efficiently. Over time, this results in steady and significant weight loss.
While both drugs are effective, their exact impact varies from person to person. Some individuals may respond better to semaglutide, while others may find tirzepatide more effective due to the added GIP action.
Understanding how these medications work helps explain their success in medical weight loss treatments. By changing the way the body processes food and energy, tirzepatide and semaglutide offer a scientific approach to sustainable weight management.
Are Tirzepatide and Semaglutide Safe?
Both tirzepatide and semaglutide are prescription medications used for weight loss and diabetes management. While they are effective, it is important to understand their safety. Like all medications, they have potential side effects and risks. People considering these treatments should know what to expect and when to seek medical advice.
Common Side Effects
Most people experience mild to moderate side effects when starting tirzepatide or semaglutide. These side effects usually improve over time as the body adjusts to the medication. The most common side effects include:
- Nausea – Feeling sick to the stomach is one of the most common side effects. Some people may feel slightly queasy, while others may have strong nausea that affects their appetite.
- Vomiting – Some people may vomit, especially during the first few weeks of treatment. This happens more often if they eat large meals or fatty foods.
- Diarrhea – Loose or frequent stools can occur, sometimes leading to dehydration if not managed properly.
- Constipation – Others may experience the opposite problem, with difficulty passing stools. Staying hydrated and eating fiber-rich foods can help.
- Abdominal pain – Some people report cramping or discomfort in their stomach area.
Doctors often recommend starting with a low dose and gradually increasing it to reduce these side effects. Eating smaller meals and avoiding greasy or spicy foods can also help manage nausea and stomach issues.
More Serious Risks
While uncommon, some people may develop serious complications from these medications. Understanding these risks helps with early detection and management.
- Pancreatitis – This is an inflammation of the pancreas, which can cause severe pain in the upper abdomen, nausea, and vomiting. It is a medical emergency and requires immediate attention. Studies show that GLP-1 medications may slightly increase the risk of pancreatitis, so people with a history of this condition should talk to their doctor before starting treatment.
- Thyroid Tumors – Animal studies have shown that drugs like tirzepatide and semaglutide may cause thyroid tumors, including medullary thyroid carcinoma (MTC). However, it is unclear if this risk applies to humans. People with a family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN2) should avoid these medications.
- Gallbladder Problems – Some people may develop gallstones or gallbladder inflammation (cholecystitis) while taking these drugs. Symptoms include severe stomach pain, nausea, vomiting, and yellowing of the skin (jaundice). Losing weight too quickly can also contribute to gallstone formation. Doctors may recommend monitoring for gallbladder issues, especially in people with a history of gallstones.
- Low Blood Sugar (Hypoglycemia) – When used with other diabetes medications like insulin or sulfonylureas, these drugs can cause blood sugar to drop too low. Symptoms of hypoglycemia include dizziness, sweating, confusion, shakiness, and weakness. Adjusting diabetes medications may be necessary to prevent this.
- Kidney Issues – Severe dehydration from vomiting or diarrhea can put stress on the kidneys, potentially leading to kidney injury. People with kidney disease should be closely monitored when using tirzepatide or semaglutide. Drinking enough fluids can help protect kidney function.
Who Should Be Careful When Using These Medications?
Certain groups of people may have a higher risk of side effects and complications. Doctors may recommend extra monitoring or suggest alternative treatments for:
- Pregnant or breastfeeding women – These drugs are not approved for use during pregnancy, and their effects on unborn babies are unknown. Women who plan to become pregnant should stop the medication at least one month before trying to conceive.
- People with a history of pancreatitis – Since there is a possible link between GLP-1 drugs and pancreatitis, those who have had this condition before should discuss the risks with their doctor.
- Individuals with thyroid cancer risk – Those with a family history of medullary thyroid cancer or MEN2 should not use these medications.
- People with severe digestive disorders – Conditions like gastroparesis (delayed stomach emptying) can worsen with these drugs, leading to severe nausea and vomiting.
Monitoring and Safety Precautions
Doctors often recommend regular check-ups while using tirzepatide or semaglutide. Blood tests may be needed to check kidney function, pancreas health, and blood sugar levels. Patients should also watch for signs of serious side effects and report any unusual symptoms to their healthcare provider.
Although these medications have risks, they are generally safe for most people when used correctly. Understanding potential side effects and knowing when to seek medical help can make treatment safer and more effective.
How Do You Take Tirzepatide and Semaglutide?
Both tirzepatide and semaglutide are injectable medications that help with weight loss by regulating appetite and blood sugar levels. They are designed to be taken once a week, which makes them convenient compared to daily medications. Understanding how to take these medications correctly is important to ensure the best results while minimizing side effects.
Dosage Forms and Strengths
Tirzepatide is available under the brand name Mounjaro, while semaglutide is sold as Wegovy for weight loss and Ozempic for type 2 diabetes. Both medications come in pre-filled injection pens that deliver a specific dose. The doses are measured in milligrams (mg) and are adjusted over time to allow the body to get used to the medication.
- Tirzepatide (Mounjaro) doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg
- Semaglutide (Wegovy) doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg
For both medications, the starting dose is lower to reduce the chances of side effects. The dose is gradually increased over several weeks until the full strength is reached.
Recommended Dosing Schedules and Titration
Doctors follow a step-by-step approach to increasing the dose, which is called titration. The goal is to allow the body to adjust to the medication while reducing the risk of nausea and vomiting, which are common side effects.
- Tirzepatide (Mounjaro) Dosing Schedule:
- Start with 2.5 mg once a week for 4 weeks
- Increase to 5 mg once a week for at least 4 weeks
- If needed, further increases to 7.5 mg, 10 mg, 12.5 mg, or 15 mg every 4 weeks, based on how well the patient tolerates it
- Semaglutide (Wegovy) Dosing Schedule:
- Start with 0.25 mg once a week for 4 weeks
- Increase to 0.5 mg once a week for 4 weeks
- If needed, increase to 1 mg, 1.7 mg, and finally 2.4 mg every 4 weeks
It may take 3 to 5 months to reach the full dose. Some people stay on a lower dose if they are achieving good results or if they experience strong side effects at higher doses.
How to Administer the Injection
Both medications are injected under the skin (subcutaneous injection), usually in the stomach (abdomen), thigh, or upper arm. The injection should not be given into a muscle or vein.
Here’s how to properly inject the medication:
- Choose an Injection Site
- The best spots are the abdomen, thigh, or upper arm.
- Rotate injection sites each week to prevent skin irritation.
- Avoid injecting too close to the belly button or into moles, scars, or damaged skin.
- Prepare the Injection Pen
- Each pen is pre-filled and already contains the correct amount of medication.
- Check the liquid inside the pen—it should be clear and colorless. If it looks cloudy or has particles, do not use it.
- Inject the Medication
- Remove the cap and attach a new needle (if required).
- Pinch a small section of skin and insert the needle at a 90-degree angle.
- Press the injection button and hold it for about 10 seconds to make sure all the medicine is injected.
- Dispose of the Needle Safely
- Use a sharps container or a thick plastic container with a secure lid to dispose of used needles.
- Never reuse a needle or share pens with anyone else.
Tips for a Successful Injection Routine
- Pick the same day each week to take the medication. Some people set reminders or link it to an existing habit, like Sunday breakfast.
- Take it at any time of the day, but keep the timing consistent.
- If you forget a dose, take it as soon as you remember, unless it’s been more than 4 days (96 hours). If it’s too close to the next scheduled dose, skip the missed dose and continue as usual.
- Store the pens properly: Keep them in the refrigerator until first use. After opening, some pens can be stored at room temperature for up to 4 weeks, but check the manufacturer’s instructions.
Adjustments for Side Effects and Individual Tolerance
During the first few weeks, some people experience nausea, diarrhea, or reduced appetite. These side effects usually improve as the body adjusts. Here are some ways to manage them:
- Eat small, frequent meals instead of large meals.
- Avoid greasy or spicy foods that can make nausea worse.
- Stay hydrated by drinking water or electrolyte drinks.
- Take the injection before bed so that side effects occur while sleeping.
If the side effects are severe or don’t improve, a doctor may pause the dose increase or lower the dose.
Why Correct Usage Matters
Taking tirzepatide or semaglutide exactly as prescribed is important to get the best weight loss results. Missing doses or stopping suddenly can lead to reduced effectiveness or possible weight regain. Those who follow their dosing schedule and make lifestyle changes—such as eating healthier and staying active—tend to see the best long-term success.
These medications are powerful tools for weight loss, but they work best when combined with a consistent routine and healthy habits.
What Are the Differences in Cost and Insurance Coverage?
The cost of weight loss medications like tirzepatide and semaglutide is a major concern for many people. These drugs can be expensive, especially without insurance coverage. Understanding their pricing, insurance options, and savings programs can help people plan for the cost of treatment.
How Much Do Tirzepatide and Semaglutide Cost?
Both tirzepatide and semaglutide are injectable medications that are taken once a week. Since they are newer drugs, they do not have generic versions yet, which makes them more expensive.
- Tirzepatide (Zepbound/Mounjaro) costs around $1,000 to $1,200 per month without insurance. The exact price can vary depending on the pharmacy and location.
- Semaglutide (Wegovy/Ozempic) costs between $900 and $1,300 per month without insurance. Prices vary depending on the dose and where it is purchased.
These prices are for people paying out-of-pocket. Many insurance plans can help lower the cost, but coverage depends on the reason the drug is prescribed.
Does Insurance Cover Tirzepatide and Semaglutide?
Insurance coverage depends on the drug’s FDA-approved use and the individual’s health plan.
- For Type 2 Diabetes: Insurance plans are more likely to cover these medications if they are prescribed for diabetes. Mounjaro (tirzepatide) and Ozempic (semaglutide) are approved for type 2 diabetes and are often covered by insurance for this use.
- For Weight Loss: Coverage is less common when these drugs are used for weight loss. Zepbound (tirzepatide) and Wegovy (semaglutide) are approved for weight loss, but some insurance companies do not cover obesity medications.
Even when insurance covers these drugs, there may be restrictions. Some insurance plans require prior authorization, which means a doctor must prove the medication is necessary before the insurance company agrees to cover it. Other plans may limit coverage to people with a certain body mass index (BMI) or those with weight-related health conditions like high blood pressure or sleep apnea.
How to Check Insurance Coverage
To find out if tirzepatide or semaglutide is covered, people should:
- Contact Their Insurance Company – The best way to know if a medication is covered is to call the insurance company or check its website. Asking specifically about the brand name (Zepbound, Mounjaro, Wegovy, or Ozempic) can give the most accurate information.
- Ask a Doctor or Pharmacist – Healthcare providers can often help with insurance questions and may know about alternative ways to lower costs.
- Check Employer Benefits – Some employers offer extra coverage for weight loss medications.
Manufacturer Savings Programs and Coupons
The companies that make these medications offer savings programs to help reduce costs. These programs are usually for people with insurance, but some may help those without insurance as well.
- Tirzepatide (Zepbound/Mounjaro): The manufacturer, Eli Lilly, offers a savings card that can lower the price for eligible patients. Some insured patients may pay as little as $25 per month if their plan covers the drug. If insurance does not cover it, discounts may still apply, but the out-of-pocket cost will be higher.
- Semaglutide (Wegovy/Ozempic): Novo Nordisk provides savings programs for people with commercial insurance. If the medication is covered, some patients may pay as little as $25 per month for Wegovy or Ozempic. Those without coverage may still get some discounts, but the final price will depend on their situation.
These savings programs have eligibility requirements, such as income limits or insurance restrictions. People can check the manufacturers’ websites for the latest details.
Ways to Reduce Costs Without Insurance
For those without insurance coverage, there are still some options to lower the cost of tirzepatide or semaglutide:
- Pharmacy Discount Cards – Programs like GoodRx, SingleCare, or Optum Perks can provide discounts at major pharmacies. These discounts can sometimes reduce the cost by several hundred dollars per month.
- Patient Assistance Programs – Some nonprofit organizations and drug manufacturers offer free or low-cost medications for people who meet income requirements. Programs like the Lilly Cares Foundation or Novo Nordisk Patient Assistance Program may help eligible patients.
- Compounded Medications – Some pharmacies make compounded semaglutide, which is a version of the drug created by a compounding pharmacy. However, compounded drugs are not FDA-approved, so there are risks involved. People should consult their doctor before using them.
- Shopping Around – Prices can vary between pharmacies. Checking different pharmacies, including online and independent pharmacies, can sometimes lead to lower prices.
Future Changes in Pricing and Insurance Coverage
As more people use GLP-1 medications for weight loss, insurance coverage may expand. Some health plans are starting to recognize obesity as a chronic disease and may begin covering more weight loss treatments. Additionally, once generic versions of tirzepatide and semaglutide become available in the future, prices are expected to drop. However, this could take several years.
For now, people considering these medications should check their insurance options, look for discounts, and talk to their doctors about the best way to afford treatment.
Can You Take Tirzepatide or Semaglutide Without Diabetes?
Tirzepatide and semaglutide are both medications originally developed to help people with type 2 diabetes control their blood sugar. However, researchers quickly noticed that people taking these medications were also losing a significant amount of weight. This led to further studies on their effects in people without diabetes, especially those struggling with obesity or overweight conditions.
Both medications are now approved for weight loss in people who do not have diabetes, but there are important details to understand before considering them as a treatment option.
FDA Approvals for Weight Loss
Tirzepatide and semaglutide are approved by the U.S. Food and Drug Administration (FDA) for different purposes:
- Semaglutide (Wegovy) is specifically approved for chronic weight management in adults and adolescents with obesity or overweight conditions, even if they do not have diabetes. The approval is based on clinical trials showing significant weight loss in people without diabetes.
- Tirzepatide (Zepbound) was approved for weight loss in 2023. Like semaglutide, it is meant for people with obesity or those who are overweight with at least one weight-related health problem, such as high blood pressure or high cholesterol.
- Other Forms of These Medications (such as Ozempic for semaglutide and Mounjaro for tirzepatide) are approved only for type 2 diabetes but are sometimes prescribed “off-label” for weight loss.
Who Can Take Tirzepatide or Semaglutide for Weight Loss?
People who do not have diabetes can take these medications if they meet certain criteria:
- Body Mass Index (BMI) of 30 or Higher – This is the standard definition of obesity.
- BMI of 27 or Higher with a Weight-Related Health Condition – Conditions like high blood pressure, high cholesterol, or sleep apnea can make weight loss a medical necessity.
Doctors typically assess a patient’s health history and current condition before prescribing these medications.
How Do These Medications Work in People Without Diabetes?
Even though tirzepatide and semaglutide were originally designed for diabetes, they work in ways that make them effective for weight loss in people without diabetes as well.
- Suppressing Appetite
- Both medications work by mimicking natural hormones (GLP-1 and, for tirzepatide, GIP) that help regulate appetite and digestion.
- These hormones send signals to the brain to reduce hunger, making it easier to eat less.
- Many people report feeling full after eating smaller amounts of food, which naturally leads to lower calorie intake.
- Slowing Digestion
- The medications slow down how quickly food leaves the stomach.
- This keeps people feeling full for longer periods and helps control cravings.
- Improving Metabolism
- Even in people without diabetes, these drugs help the body process sugars and fats more efficiently.
- They may reduce fat storage and improve the way the body burns calories.
- Changing Food Preferences
- Some people notice changes in what foods they crave, often feeling less desire for high-fat or high-sugar foods.
- This can make it easier to develop healthier eating habits over time.
Do People Without Diabetes Experience the Same Side Effects?
Yes, people who take these medications for weight loss can experience the same side effects as those taking them for diabetes. Common side effects include:
- Nausea and Vomiting – More common when starting the medication but often improves over time.
- Diarrhea or Constipation – The slowing of digestion can cause changes in bowel habits.
- Fatigue – Some people feel more tired than usual, especially in the first few weeks.
More serious side effects, such as pancreatitis, gallbladder problems, and thyroid issues, are rare but possible. Doctors monitor for these risks, especially in people with a family history of such conditions.
Do People Without Diabetes Lose More or Less Weight?
Studies show that people without diabetes tend to lose more weight on these medications than those with diabetes. This is because:
- People with diabetes often have insulin resistance, which can slow weight loss.
- Those without diabetes may respond better to the appetite-suppressing effects.
For example, in the STEP trials (which studied semaglutide for weight loss), people without diabetes lost an average of 15% of their body weight over 68 weeks. In comparison, people with diabetes lost about 10% to 12% of their body weight.
Similarly, the SURMOUNT trials (which studied tirzepatide) showed that people without diabetes lost up to 22.5% of their body weight in about 16 months.
Considerations Before Taking These Medications Without Diabetes
- Cost and Insurance Coverage
- Insurance companies are more likely to cover these drugs for diabetes than for weight loss.
- Out-of-pocket costs can be high, sometimes exceeding $1,000 per month.
- Some manufacturers offer savings programs, but eligibility depends on income and insurance status.
- Long-Term Use
- Weight regain is common after stopping these medications.
- Many people may need to take them long-term to maintain weight loss.
- Lifestyle Changes Are Still Needed
- These medications are most effective when combined with a healthy diet and regular exercise.
- Relying on the medication alone without changing eating habits or activity levels may lead to less sustainable results.
People without diabetes can safely take tirzepatide or semaglutide for weight loss if they meet the necessary medical criteria. Clinical trials have shown that they are effective in helping non-diabetic individuals lose significant weight by reducing hunger, slowing digestion, and improving metabolism. However, potential side effects, costs, and long-term weight management strategies should be considered before starting treatment. Consulting a healthcare provider is the best way to determine if these medications are a suitable option.
How Long Do You Have to Take Tirzepatide or Semaglutide for Weight Loss?
Tirzepatide and semaglutide are powerful weight loss medications, but many people wonder how long they need to stay on them to maintain results. The answer depends on multiple factors, including individual goals, response to treatment, and long-term health planning.
Recommended Treatment Duration
Clinical trials have shown that both tirzepatide and semaglutide lead to significant weight loss when taken consistently. Most studies have followed participants for about 68 to 72 weeks (roughly 1.5 years). During this period, people using these medications under medical supervision experienced steady weight loss.
The medications work best when used alongside a healthy diet and regular exercise. Doctors usually recommend staying on them for at least a year to achieve significant and sustainable weight loss. However, the ideal duration varies from person to person. Some individuals may reach their goal weight sooner, while others may need more time.
What Happens if You Stop Taking the Medication?
One major concern is weight regain after stopping tirzepatide or semaglutide. Studies have found that many people regain a significant portion of the weight they lost once they stop taking the medication.
This happens because these drugs help regulate appetite and blood sugar levels. When the medication is discontinued, hunger often returns, and metabolism may slow down slightly. This can make it harder to maintain weight loss without continued lifestyle changes.
In clinical trials, participants who stopped taking semaglutide regained about two-thirds of the weight they had lost within a year. Similar trends have been seen with tirzepatide. This suggests that these medications may need to be taken long-term to maintain weight loss, similar to how medications for high blood pressure or diabetes are taken indefinitely.
Are There Strategies to Prevent Weight Regain?
While stopping the medication can lead to weight regain, there are steps to help maintain weight loss:
- Lifestyle Changes: Eating a balanced diet with lean proteins, healthy fats, and fiber can help control hunger even after stopping the medication. Regular physical activity, including strength training and cardio exercises, also supports long-term weight maintenance.
- Gradual Tapering: Some healthcare providers may suggest slowly reducing the dose instead of stopping suddenly. This may help the body adjust to lower medication levels.
- Ongoing Medical Support: Working with a doctor, nutritionist, or weight management specialist can provide guidance on maintaining weight loss after stopping the medication.
Can You Take Tirzepatide or Semaglutide for Life?
For some individuals, long-term or even lifelong use of these medications may be necessary, just like with diabetes or high blood pressure medications. Doctors consider factors such as:
- Obesity as a Chronic Condition: If obesity is treated as a long-term medical issue, ongoing treatment may be needed to prevent weight regain and related health risks.
- Other Health Benefits: These drugs not only help with weight loss but also improve blood sugar control, reduce inflammation, and lower the risk of heart disease. Staying on the medication may have additional health benefits beyond weight management.
- Individual Response to the Drug: Some people respond exceptionally well to the medication and may choose to continue using it if they experience minimal side effects and long-term benefits.
When Might Someone Stop Taking the Medication?
While some people may need long-term treatment, others may stop taking tirzepatide or semaglutide due to:
- Reaching Their Goal Weight and Successfully Maintaining It: If someone achieves their weight loss goal and can maintain it through diet and exercise, they may decide to stop the medication.
- Side Effects: Some individuals experience ongoing nausea, vomiting, or other side effects that make continued use difficult.
- Cost and Insurance Issues: These medications can be expensive, and insurance coverage may change over time, making it difficult for some people to afford them.
- Personal Preference: Some individuals may prefer not to take medication long-term and instead focus on lifestyle changes alone.
The length of time someone should take tirzepatide or semaglutide depends on personal health goals, response to treatment, and the ability to maintain weight loss without the medication. Many people benefit from using these medications for at least a year, and some may need long-term treatment to prevent weight regain. Consulting a healthcare provider is the best way to determine the right duration based on individual needs.
What Are the Key Differences Between Tirzepatide and Semaglutide?
Tirzepatide and semaglutide are two powerful medications used for weight loss and diabetes management. While they share some similarities, they also have key differences that affect how they work, their effectiveness, side effects, cost, and availability. Understanding these differences can help people decide which medication might be a better fit for their needs.
How They Work: Tirzepatide vs. Semaglutide
Both tirzepatide and semaglutide belong to a class of drugs called GLP-1 receptor agonists. These medications help regulate blood sugar levels and reduce appetite by mimicking a natural hormone in the body. However, tirzepatide has an additional function that sets it apart.
- Semaglutide only activates the GLP-1 receptor. This receptor helps lower blood sugar, slows digestion, and reduces hunger.
- Tirzepatide activates both the GLP-1 receptor and the GIP receptor (glucose-dependent insulinotropic polypeptide). The GIP receptor plays a role in fat metabolism and insulin release, which may enhance weight loss effects.
Because tirzepatide targets two different pathways, some researchers believe it might be more effective at helping people lose weight compared to semaglutide.
Effectiveness for Weight Loss
Both medications have been studied in large clinical trials, where researchers measured how much weight people lost while taking them.
- Semaglutide (Wegovy, Ozempic) has been shown to help people lose about 15% of their body weight when used for weight loss.
- Tirzepatide (Mounjaro, Zepbound) has been shown to help people lose up to 20-22% of their body weight in some studies.
While both medications lead to significant weight loss, clinical trials suggest that tirzepatide may be slightly more effective than semaglutide. However, results can vary from person to person. Some people respond better to one medication than the other based on their body’s metabolism and other factors.
Side Effects and Tolerability
Both medications have similar side effects because they slow down digestion and affect appetite. The most common side effects include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
These side effects often occur when people first start the medication or increase their dose. They usually get better over time as the body adjusts.
Tirzepatide and semaglutide also have some serious but rare risks, including:
- Pancreatitis (inflammation of the pancreas)
- Gallbladder problems (such as gallstones)
- Thyroid C-cell tumors (based on animal studies, but not confirmed in humans)
Since both medications have similar side effects, choosing between them may come down to how well someone tolerates one over the other. Some people experience stronger nausea or digestive issues with semaglutide, while others may feel the same with tirzepatide.
Cost and Insurance Coverage
The cost of these medications depends on factors like insurance coverage, location, and whether the medication is used for diabetes or weight loss.
- Semaglutide (Ozempic, Wegovy) can cost $900 to $1,400 per month without insurance.
- Tirzepatide (Mounjaro, Zepbound) costs about $1,000 to $1,200 per month without insurance.
Insurance coverage can be a major factor in affordability. Many insurance companies cover Ozempic (semaglutide for diabetes) and Mounjaro (tirzepatide for diabetes), but they may not cover Wegovy or Zepbound (the versions approved for weight loss). Patients sometimes need to go through a prior authorization process to get insurance approval for weight-loss use.
Manufacturers offer savings programs that can lower costs for eligible patients. However, availability and restrictions vary, so it’s important to check with insurance providers and pharmacies.
Availability and FDA Approval
Both medications are available by prescription, but they are approved for different conditions:
- Semaglutide:
- Ozempic – Approved for type 2 diabetes
- Wegovy – Approved for weight loss
- Tirzepatide:
- Mounjaro – Approved for type 2 diabetes
- Zepbound – Approved for weight loss
Doctors can prescribe either medication for weight loss, even if it is not their primary approval. This is called off-label use. However, insurance may not cover off-label prescriptions, making it more expensive for some patients.
Choosing Between Tirzepatide and Semaglutide
Deciding which medication is better depends on a person’s health goals, medical history, side effects, and cost considerations.
- Tirzepatide may be the better option for:
- People looking for slightly greater weight loss
- Those who want the additional benefits of GIP activation
- People whose insurance covers Mounjaro or Zepbound at a lower cost
- Semaglutide may be the better option for:
- People who tolerate GLP-1 receptor agonists well
- Those who can get Wegovy or Ozempic covered by insurance
- People who want a medication with a longer track record for weight loss
Since both medications are effective, the decision often comes down to availability, side effects, and individual response to treatment.
Future of GLP-1 and GIP Medications
Researchers are continuing to develop new treatments that build on the success of tirzepatide and semaglutide. Some future medications may combine additional hormones or improve how these drugs work in the body. The next generation of weight loss drugs may offer even better results with fewer side effects.
For now, tirzepatide and semaglutide remain two of the most powerful options for weight loss available today. Anyone considering these medications should talk to a doctor to find the best choice based on their health and lifestyle.
Conclusion
Tirzepatide and semaglutide have emerged as two of the most powerful medications for weight loss in recent years. Both drugs work by affecting hormones in the body that control hunger, digestion, and blood sugar levels. While they were first developed to treat type 2 diabetes, they have shown impressive results in helping people lose weight, even those without diabetes. Understanding the differences between these two medications is important for anyone considering them as a treatment option.
One of the biggest differences between tirzepatide and semaglutide is how they work. Semaglutide is a GLP-1 receptor agonist, which means it mimics a hormone called glucagon-like peptide-1 (GLP-1). This hormone helps reduce hunger, slows down digestion, and improves how the body handles sugar. Tirzepatide, on the other hand, is a dual agonist, meaning it works on two different hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). By activating both, tirzepatide may have a stronger effect on appetite control and metabolism than semaglutide.
Because of these differences, studies have found that tirzepatide may lead to more weight loss compared to semaglutide. Clinical trials show that people taking tirzepatide lost up to 22.5% of their body weight, while those taking semaglutide lost about 15%. This means that someone weighing 200 pounds could lose around 45 pounds with tirzepatide compared to 30 pounds with semaglutide. However, results vary from person to person, and not everyone responds the same way to these medications.
When considering safety, both medications have similar side effects. The most common ones are nausea, vomiting, diarrhea, and constipation. These effects usually happen when starting the medication and may get better over time. However, some people experience more serious side effects like gallbladder problems, pancreatitis, and changes in thyroid health. Because of these risks, it is important for patients to talk to their doctor before starting either medication. Doctors may monitor patients closely, especially in the first few months of treatment.
Another factor to consider is how these medications are taken. Both tirzepatide and semaglutide are injected once a week. This makes them easier to use compared to older weight loss medications that required daily pills or multiple injections per week. The dosing schedule is different for each drug. Semaglutide typically starts at a low dose and increases gradually over time. Tirzepatide also follows a similar pattern, with doses adjusted based on how well a patient tolerates the medication.
Cost and insurance coverage are also important considerations. Both drugs are expensive without insurance, costing over $1,000 per month. However, insurance may cover them for people with type 2 diabetes. For those using them only for weight loss, getting coverage can be more difficult. Some drug manufacturers offer savings programs to help reduce the cost, but access varies depending on location and insurance policies.
Many people wonder whether these medications can be used by those who do not have diabetes. The answer is yes—both have been approved for weight loss in people who are overweight or obese, even if they do not have diabetes. However, they are not intended for casual weight loss in people who are only slightly overweight. Doctors usually prescribe these medications to people who have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions like high blood pressure or sleep apnea.
Another common question is how long someone should take tirzepatide or semaglutide. Clinical trials suggest that these medications work best when taken long-term. If someone stops using them, they may regain the weight they lost. This happens because the body’s natural hunger signals return, leading people to eat more again. To maintain weight loss, it is important to continue healthy eating habits, exercise regularly, and follow medical advice.
Looking at the overall picture, both tirzepatide and semaglutide are excellent options for weight loss. They help reduce appetite, improve metabolism, and lead to significant weight reduction for many patients. Tirzepatide may provide greater weight loss compared to semaglutide, but both drugs have strong clinical support. The choice between the two depends on factors like personal response to the medication, cost, insurance coverage, and individual health conditions.
Before starting either medication, it is important to consult with a healthcare provider. A doctor can assess a person’s health history, discuss possible risks, and determine which medication might be the best fit. Since these drugs affect blood sugar and digestion, they may not be suitable for everyone. People with certain medical conditions, such as thyroid cancer or severe gastrointestinal issues, may need to consider other options.
As research continues, scientists are exploring even more advanced treatments for weight loss and metabolic health. New medications are being developed that may offer better results with fewer side effects. In the future, we may see even more powerful and accessible weight loss treatments.
In conclusion, tirzepatide and semaglutide have changed the landscape of medical weight loss. They provide new hope for people struggling with obesity and related health conditions. While both drugs are highly effective, the decision on which to use should be made with the guidance of a doctor. With the right approach, these medications can be a valuable tool in achieving long-term weight management and improved health.
Research Citations
Frias, J. P., Nauck, M. A., Van J., et al. (2018). Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: A randomized, placebo-controlled, and active comparator-controlled phase 2 trial. The Lancet, 392(10160), 2180–2193. https://doi.org/10.1016/S0140-6736(18)31641-8
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once‐weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
Qin, W., Yang, J., Ni, Y., et al. (2024). Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: An updated systematic review and meta-analysis. Endocrine, 86, 70–84. https://doi.org/10.1007/s12020-024-03896-z
Nauck, M. A., & Meier, J. J. (2022). Incretin-based therapies: How do they work and what are the benefits? Diabetes Care, 45(1), 25–33. https://doi.org/10.2337/dc21-1562
Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2024). Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program. Obesity, 31(1), 96–110. https://doi.org/10.1002/oby.23222
Holst, J., Bloch, P., Schäffer, L., et al. (2015). Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry, 58(18), 7370–7380. https://doi.org/10.1021/acs.jmedchem.5b00726
Aroda, V. R., Ahmann, A., Cariou, B., et al. (2019). Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials. Diabetes & Metabolism, 45(5), 409–418. https://doi.org/10.1177/2040622319843750
Sampath, S. (2025, February 24). Semaglutide: A promising solution for weight loss in fatty liver disease. Medindia. Retrieved March 7, 2025, from
Questions and Answers: Tirzepatide or Semaglutide for Weight Loss
Tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) are injectable medications that mimic gut hormones (GLP-1 for semaglutide; GLP-1 and GIP for tirzepatide). They help with weight loss by reducing appetite, slowing digestion, and improving insulin sensitivity.
Clinical studies suggest that tirzepatide leads to greater weight loss than semaglutide. Tirzepatide users can lose around 20-25% of body weight, while semaglutide users lose about 15-17% on average.
Most people start seeing noticeable weight loss within the first 4–8 weeks, with significant results after 3–6 months. Maximum weight loss usually occurs after 12–18 months of consistent use.
Yes, semaglutide is FDA-approved for weight loss under the brand name Wegovy. Tirzepatide was originally approved for diabetes (Mounjaro) but is now FDA-approved for weight loss under the name Zepbound.
The most common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite. Some people also experience fatigue, dizziness, or burping with a bad taste (more common with tirzepatide).
Yes, both tirzepatide (Zepbound) and semaglutide (Wegovy) are approved for weight loss in people without diabetes, as long as they meet BMI criteria (BMI ≥30 or ≥27 with weight-related conditions).
Weight regain is common after stopping these medications unless lifestyle changes are maintained. Studies show that most people regain a significant portion of lost weight within a year of stopping treatment.
Yes, they have been studied for long-term use, but ongoing research is still evaluating their safety over many years. No major long-term safety concerns have been identified so far, but risks like pancreatitis and thyroid tumors remain under observation.
Most people can, but they are not recommended for those with a history of medullary thyroid cancer, multiple endocrine neoplasia type 2 (MEN2), or severe gastrointestinal issues. Always consult your doctor before starting.
Without insurance, Wegovy (semaglutide) costs around $1,300 per month, and Zepbound (tirzepatide) is similarly priced. Insurance coverage varies; some plans cover them for weight loss, while others do not. Manufacturer savings programs may help reduce costs.
